Nivolumab associated myasthenia gravis with severly elevated cardiac biomarkers: to treat or not to treat?

29 June 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Clinical Case Award Cardio-Oncology HFA Premium Access Heart Failure 2021

ESC 365 is supported by

ESC 365 is supported by